Yifan Pharmaceutical
is an innovative R&D and production company focusing on the pharmaceutical and health sectors.
Our vision is to develop innovative drugs with definite clinical values, to help disease-afflicted patients regain health.
Currently, we are focusing on four business areas, i.e., biologics, small molecules, synthetic biologics, and special traditional Chinese medicines (TCMs),
expanding our product R&D pipelines and innovating drugs for disease treatment to address unmet medical needs;
and we are striving to set up an extensive commercial network to facilitate the flow of quality drugs having reliable therapeutic effect across the world to help cure diseases.
* Data updated on December 31, 2021
-
-
2009
Establishment of manufacturing system
-
2014
Listing on the main board of Shenzhen Stock Exchange
-
2016
Establishment of Macromolecules R&D Center
-
2018
Establishment of global business network
-
2019
Establishment of Insulin Manufacturing Center
Global operation
Establishing global manufacturing and R&D systems and business network centering on core business areas.
-
Effectively supporting massive commercialized production in compliance with high standards in the industry.
Learn more
-
Our business network has spanned nearly 40 countries and regions in Southeast Asia, Europe and North America, including China, ROK, Italy, and the U.S.
Learn more
